Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 503301 - 503320 out of 504621 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01FX17) sacituzumab govitecan | TRODELVY | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Triple Negative Breast Neoplasms | GileadSciences,Inc. |
| USA | (L01FX23) tisotumab vedotin | TIVDAK 40MG VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Uterine Cervical Neoplasms | PfizerInc. |
| USA | (L01FX23) tisotumab vedotin | TIVDAK 40MG VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Uterine Cervical Neoplasms | PfizerInc. |
| USA | (L01FX32) elranatamab | ELREXFIO 44MG/1.1ML INJ,SOLN | 1.1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | PfizerInc. |
| USA | (L01FX32) elranatamab | ELREXFIO 44MG/1.1ML INJ,SOLN | 1.1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | PfizerInc. |
| USA | (L01FX32) elranatamab | ELREXFIO 76MG/1.9ML INJ,SOLN | 1.9ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | PfizerInc. |
| USA | (L01FX32) elranatamab | ELREXFIO 76MG/1.9ML INJ,SOLN | 1.9ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | PfizerInc. |
| USA | (L01FX35) datopotamab deruxtecan | DATROWAY 100MG/VIAL INJ,LY | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | DaiichiSankyo,Inc. |
| USA | (L01FX35) datopotamab deruxtecan | DATROWAY 100MG/VIAL INJ,LY | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | DaiichiSankyo,Inc. |
| USA | (L01XA03) oxaliplatin | OXALIPLATIN INJECTION 5MG/ML 1X10ML GLASS | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | TevaPharmaceuticalsUSA,Inc. |
| USA | (L01XA03) oxaliplatin | OXALIPLATIN INJECTION 5MG/ML 1X10ML GLASS | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | TevaPharmaceuticalsUSA,Inc. |
| USA | (L01XA03) oxaliplatin | OXALIPLATIN INJECTION 5MG/ML 1X20ML GLASS | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | TevaPharmaceuticalsUSA,Inc. |
| USA | (L01XA03) oxaliplatin | OXALIPLATIN INJECTION 5MG/ML 1X20ML GLASS | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | TevaPharmaceuticalsUSA,Inc. |
| USA | (L01XC) monoclonal antibodies | OPDIVO QVANTIG | 5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Bristol-MyersSquibbCompany |
| USA | (L01XF03) bexarotene | TARGRETIN 1% GEL | 60GM | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, T-Cell, Cutaneous | BauschHealthUS,LLC |
| USA | (L01XF03) bexarotene | TARGRETIN 1% GEL | 60GM | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, T-Cell, Cutaneous | BauschHealthUS,LLC |
| USA | (L01XF03) bexarotene | TARGRETIN 75MG CAP | 100 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, T-Cell, Cutaneous | BauschHealthUS,LLC |
| USA | (L01XF03) bexarotene | TARGRETIN 75MG CAP | 100 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, T-Cell, Cutaneous | BauschHealthUS,LLC |
| USA | (L01XG01) bortezomib | VELCADE 3.5MG F/INJ VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L01XG01) bortezomib | VELCADE 3.5MG F/INJ VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | TakedaPharmaceuticalsAmerica,Inc. |
Pages
